On Wednesday, Following Stocks were among the “Top Losers” of U.S. Stock Market: Campus Crest Communities, (NYSE:CCG), FreeSeas, (NASDAQ:FREE), Carpenter Technology, (NYSE:CRS), Raptor Pharmaceuticals, (NASDAQ:RPTP)
Campus Crest Communities, (NYSE:CCG), with shares declined -9.78%, closed at $6.46, hitting new 52-week low of $5.80.
FreeSeas, (NASDAQ:FREE), with shares dropped -8.94%, settled at $0.04, hitting new 52-week low of $0.04.
Carpenter Technology, (NYSE:CRS), with shares dipped -8.20%, and closed at $35.69.
Raptor Pharmaceuticals, (NASDAQ:RPTP), plummeted -8.19%, and closed at $9.98.
Latest NEWS regarding these Stocks are depicted underneath:
Campus Crest Communities, Inc. (NYSE:CCG)
Campus Crest Communities, Inc. (CCG), declared an update to its anticipated dividend payments.`
In connection with the filing of its Form 10-K for the fiscal year ended December 31, 2014, the Corporation noted that for 2015, the Corporation does not anticipate being subject to any REIT-required minimum distributions. Therefore, the Board of Directors does not anticipate declaring any dividend payments for 2015, and the Corporation presently does not intend to make distributions to ordinary stockholders in 2015, unless it successfully effects certain asset sales, raises additional capital, refinances its existing credit facilities, and/or experiences sufficient improvement in operating results.
Additionally, the Corporation is suspending dividend payment on its Series A Cumulative Redeemable Preferred Shares. However, dividends on the Series A Preferred Stock will accrue at the effective annual rate of $2.00 per share until paid.
Campus Crest Communities, Inc., a real estate investment trust (REIT), engages in the ownership, development, building, and administration of student housing properties under the Grove brand name in the United States.
FreeSeas Inc. (NASDAQ:FREE)
FreeSeas Inc. (FREE),
FreeSeas Inc., through its auxiliaries, provides drybulk shipping services. Its vessels carry various drybulk commodities, such as iron ore, grain, and coal, in addition to bauxite, phosphate, fertilizers, steel products, cement, sugar, and rice. Its fleet comprises of five Handysize vessels and one Handymax vessel.
Carpenter Technology Corp. (NYSE:CRS)
Carpenter Technology Corp. (CRS), declared restructuring actions to reduce fixed overhead costs and position the Corporation to drive long-term, profitable growth. The actions are precipitated by the Corporation’s desire to improve operating cost performance and the current weakness in the Oil and Gas market, and they are part of an overall plan to deliver greater value to shareholders by strengthening the Corporation’s performance as a specialty alloys leader. The Corporation’s restructuring actions are predictable to yield about $30 million of annual fixed overhead cost savings and will be complemented by additional strategies to reduce costs.
Carpenter’s Chairman, President and Chief Executive Officer Gregory A. Pratt stated, “We are confident in the technology, manufacturing capabilities, customer connections and employee dedication within our Corporation. We are clearly disappointed with our performance over the last several quarters and are taking decisive actions to return to the level of operational and financial performance we are capable of achieving, and which we and our shareholders expect and deserve.”
Carpenter Technology Corporation manufactures, fabricates, and distributes specialty metals worldwide. The corporation operates in two segments: Specialty Alloys Operations and Performance Engineered Products.
Raptor Pharmaceuticals Corp. (NASDAQ:RPTP)
Raptor Pharmaceuticals Corp. (RPTP), declared that it has commenced an underwritten public offering of $75 million of shares of its ordinary stock. In addition, the corporation is predictable to grant the underwriters of the offering an option for a period of 30 days to purchase up to an additional 15 percent of the number of shares of ordinary stock sold in the offering at the public offering price, less the underwriting discounts and commissions. All of the shares are being offered by the corporation. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be accomplished.
Citigroup, Leerink Partners and Cowen and Corporation are acting as lead joint book-running managers for the offering. JMP Securities is acting as lead manager and Janney Montgomery Scott LLC is acting as a co-manager for the offering.
Raptor Pharmaceutical Corp., a biopharmaceutical corporation, focuses on developing and commercializing life-altering therapeutics that treat debilitating and often fatal diseases. The corporation offers PROCYSBI, a delayed-release capsule, which is used for the administration of nephropathic cystinosis in adults, in addition to in six years and older children in the United States, in the 28 member states of the European Union, Norway, Liechtenstein, and Iceland.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
